Xigan He

1.2k total citations
28 papers, 706 citations indexed

About

Xigan He is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xigan He has authored 28 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xigan He's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), RNA modifications and cancer (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Xigan He is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), RNA modifications and cancer (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Xigan He collaborates with scholars based in China and Netherlands. Xigan He's co-authors include Yuchen Li, Hongyan Lai, Qin Li, Zhixiang Hu, Shenglin Huang, Yan Li, Hena Zhang, Longrong Wang, Xianghuo He and Qiupeng Zheng and has published in prestigious journals such as Hepatology, The FASEB Journal and The Journal of Physical Chemistry C.

In The Last Decade

Xigan He

28 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xigan He China 12 459 327 125 114 106 28 706
Liuxin Cai China 10 381 0.8× 205 0.6× 208 1.7× 157 1.4× 146 1.4× 18 712
Haohai Zhang China 17 372 0.8× 291 0.9× 201 1.6× 130 1.1× 71 0.7× 27 784
Bei‐Ge Jiang China 15 308 0.7× 219 0.7× 135 1.1× 73 0.6× 168 1.6× 27 650
Annalisa Lorenzato Italy 13 369 0.8× 234 0.7× 137 1.1× 117 1.0× 73 0.7× 22 698
Guangyuan Song China 16 328 0.7× 210 0.6× 153 1.2× 161 1.4× 66 0.6× 47 621
Xiaoguang Sun China 13 351 0.8× 317 1.0× 167 1.3× 117 1.0× 76 0.7× 19 756
Tian Lan China 13 435 0.9× 404 1.2× 66 0.5× 73 0.6× 62 0.6× 21 728
Qi Song China 19 523 1.1× 377 1.2× 321 2.6× 209 1.8× 101 1.0× 50 1.0k
Chun-Ying Qu China 14 271 0.6× 152 0.5× 104 0.8× 97 0.9× 62 0.6× 25 563

Countries citing papers authored by Xigan He

Since Specialization
Citations

This map shows the geographic impact of Xigan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xigan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xigan He more than expected).

Fields of papers citing papers by Xigan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xigan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xigan He. The network helps show where Xigan He may publish in the future.

Co-authorship network of co-authors of Xigan He

This figure shows the co-authorship network connecting the top 25 collaborators of Xigan He. A scholar is included among the top collaborators of Xigan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xigan He. Xigan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Runze, Xin Jin, Qinyu Liu, et al.. (2025). Genetic evidence for causal links between diet, gut microbiota, and hepatobiliary cancer: a Mendelian randomization study. AMB Express. 15(1). 100–100. 1 indexed citations
2.
Zhou, Jiamin, Xigan He, Weixing Dai, et al.. (2024). GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis. APOPTOSIS. 29(11-12). 1988–2001. 7 indexed citations
3.
Yang, Puyu, Runze Huang, Yibin Wu, et al.. (2024). Prioritization of therapeutic targets for cancers using integrative multi-omics analysis. Human Genomics. 18(1). 42–42. 4 indexed citations
4.
Feng, Yun, Yiming Zhao, Weiwei Li, et al.. (2022). Hepatic resection prolongs overall survival in the selected patients with nasopharyngeal carcinoma liver metastases. European Journal of Surgical Oncology. 48(10). 2202–2211. 3 indexed citations
5.
He, Xigan, Jiamin Zhou, Anrong Mao, et al.. (2022). LncRNA‐EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src‐YAP signaling axis. The FASEB Journal. 36(12). e22663–e22663. 9 indexed citations
6.
Zhou, Jiamin, et al.. (2021). Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy. Frontiers in Surgery. 8. 764887–764887. 8 indexed citations
7.
He, Xigan, Wangjun Yan, Y. Chen, et al.. (2021). 67P Sintilimab, doxorubicin and ifosfamide (AI) as first-line treatment in patients with advanced soft tissue sarcoma: A single-arm phase II trial. Annals of Oncology. 32. S1401–S1401. 2 indexed citations
8.
Wang, Longrong, Yiming Zhao, Qi Pan, et al.. (2020). Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience. Journal of Translational Medicine. 18(1). 273–273. 25 indexed citations
9.
Feng, Yun, Xigan He, Changming Zhou, et al.. (2020). Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study. The American Journal of Surgery. 220(4). 945–951. 16 indexed citations
10.
Wang, Longrong, Kai Yan, Xigan He, et al.. (2020). LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. Journal of Cancer. 12(1). 217–223. 36 indexed citations
11.
Wang, Longrong, Miao Wang, Xigan He, et al.. (2020). Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma. The American Journal of Surgery. 222(2). 383–389. 11 indexed citations
12.
Li, Yuchen, Xigan He, Qin Li, et al.. (2020). EV-origin: Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile. Computational and Structural Biotechnology Journal. 18. 2851–2859. 131 indexed citations
13.
Zheng, Qiupeng, Jingjing Zhao, Hui Yu, et al.. (2019). Tumor‐Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function. Hepatology. 71(1). 259–274. 18 indexed citations
14.
Wang, Guangzhi, Xigan He, Lichao Xu, et al.. (2019). Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours. Current Oncology. 26(5). 658–664. 7 indexed citations
15.
Wang, Miao, Jiamin Zhou, Yiming Zhao, et al.. (2019). Surgical treatment of ovarian cancer liver metastasis. HepatoBiliary Surgery and Nutrition. 8(2). 129–137. 19 indexed citations
16.
Li, Yuchen, Jingjing Zhao, Shulin Yu, et al.. (2019). Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis. Clinical Chemistry. 65(6). 798–808. 214 indexed citations
17.
Zhu, Weiping, Yiming Zhao, Xigan He, et al.. (2018). Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma. Cell Death and Disease. 9(2). 69–69. 16 indexed citations
18.
He, Xigan, et al.. (2018). Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis. Clinical & Translational Oncology. 21(4). 443–450. 9 indexed citations
19.
20.
Zhu, Weiping, Yiming Zhao, Jiamin Zhou, et al.. (2016). Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition. Journal of Hematology & Oncology. 9(1). 127–127. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liuxin Cai Breakdown of academic impact, for papers by Haohai Zhang Breakdown of academic impact, for papers by Bei‐Ge Jiang Breakdown of academic impact, for papers by Annalisa Lorenzato Breakdown of academic impact, for papers by Guangyuan Song Breakdown of academic impact, for papers by Xiaoguang Sun Breakdown of academic impact, for papers by Tian Lan Breakdown of academic impact, for papers by Qi Song Breakdown of academic impact, for papers by Chun-Ying Qu
Rankless by CCL
2026